Today’s episode features Amy Emerson, the CEO of MAPS Public Benefit Corporation (PBC), which is a fully owned subsidiary of MAPS, and its purpose is to commercialize MDMA-assisted therapy. We discuss the MAPS PBC and it’s business model for MDMA-assisted therapy.

In this episode, we discuss:

MAPS’ protocol and strategy behind FDA clinical trial for PTSD
Amy’s views on the state of the industry, patents, and how to prioritize accessibility
The unique business model between MAPS and MAPS PBC
Psychedelics for kids

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin and Matias Serebrinsky
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Theme music by Dorian Love
Additional music: Focus Does the Girl by Muted Circus

MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy